Tag: technology

Posts with tag: technology

Latest Posts

Formula One Unlocks New Frontiers: Unveiling 2025 Race Cars, Expanding Presence in the US

Formula One, now in its 75th season, unveils new race cars and tech in London, showcasing its growing popularity due to Netflix's "Drive to Survive" and expanding into the US market with races in Miami, Las Vegas, and Austin.

Antitrust Enforcement Under Biden-Era Standards to Continue Under Trump’s FTC

New FTC chair Andrew Ferguson is maintaining stricter merger review standards, suggesting continued scrutiny of big acquisitions under the Trump administration.

KKR Leads $1.6 Billion Debt Financing for Constellation Automotive Group

Apollo, HPS, and Hayfin join KKR in providing £1.3 billion debt for Constellation Automotive Group, owned by TDR Capital.

Thames Floats Debt at Record High as Investors Bet on Bailout

Thames Water needs cash to avoid insolvency, and investors are eager to provide it, with prices for the opportunity reaching 112% of face value in the secondary market.

U.S. Homebuilding Plunges in January

US single-family homebuilding plunged 8.4% in January due to severe weather and rising costs stemming from tariffs and high mortgage rates

Trimble Q4 profit tops expectations

Trimble Navigation Ltd. (TRMB) reported fourth-quarter profit of $90.2 million, beating Street forecasts. For the year, the company reported profit of $1.5 billion, or $6.09 per share.

SolarEdge Posts Wider-Than-Expected Q4 Loss

SolarEdge Technologies reports a Q4 loss of $287.4 million, missing analyst expectations. Revenue came in at $196.2 million, beating forecasts. For the full year, the company reported a loss of $1.81 billion on revenue of $901.5 million.

Serve Robotics Rolls Out Sidewalk Delivery Robots in Miami

Serve Robotics expands to Miami, partnering with Shake Shack and Mister O1 Extraordinary Pizza for sidewalk delivery using autonomous robots.

Karyopharm Therapeutics Reports Q4 Loss of 24 Cents Per Share, Tops Estimates

Karyopharm Therapeutics Inc. (KPTI) reported a Q4 loss of $30.8 million, or 24 cents per share, beating analyst estimates of a 26-cent loss. The company posted revenue of $30.5 million. For the year, the loss was $76.4 million, or 93 cents per share, on revenue of $145.2 million. Karyopharm Therapeutics expects full-year revenue in the range of $140 million to $155 million.

JLL Q4 Earnings Top Estimates

Jones Lang LaSalle Inc. (JLL) reported fourth-quarter earnings of $241.2 million, beating analysts' estimates. Adjusted earnings came to $6.15 per share on revenue of $6.81 billion.